Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...
14mon MSN
Other blue chips under pressure included Marks & Spencer, Barclays and Rolls-Royce, with their shares down by around 0.5%. Alongside Legal & General at the top of the FTSE 100 ind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback